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ABSTRAC'r
BK virus large T antigen expression was correlated
with the ability of BK virus transformed hamster cells to
release infectious virus after fusion with permissive human
embryonic kidney cells.

Seven clones of BK virus infected

BHK-21 cells (BK-BHK) were isolated from agar suspension
cultures when cell colonies grew to 1 mm to 2 mm in size.
All of the BK-BHK clones initiated tumors in Syrian hamsters
and maintained high plating efficiencies in 0.33% agar
suspension.

Large T antigen was detected in 4 of the BK-

BHK clones using immunofluorescence and immunoperoxidase
assays.

Infectious BK virus was rescued from 3 of the

BK-BHK clones following cell fusion.

One clone, BK-BHK-129,

was demonstrably large T antigen negative, but released
infectious BKV following cell fusion.

Subclones of the BK-

BHK-L-29 clone were also large T antigen negative virus
yielders.

However, the rescued virus was capable of trans-

forming BHK-21 cells with an efficiency comparable to wild
type BK'virus.

Large T antigen was detected in BHK-21 cells

transformed by the rescued virus.

The rescued virus DNA

was examined by inspection of restriction endonuclease
digestion fragments on agarose gels and by

s1

nuclease

digestion following hybridization to wild type BK virus DNA.
The rescued virus was indistinguishable from wild type
virus using these techniques.
iii
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Introduction

One of the most widely studied groups of viruses which
possess in vitro cell transforming ability and oncogenic
activity in animals are the papovaviruses.

The papova-

virus group includes viruses of rodent and primate origin.
The rodent polyoma virus was isolated from inbred strains
of mice in 1953 by Gross (33), and was found capable of
inducing multiple types of tumors in hamsters and mice (91).
The primate papovaviruses consist of the simian virus 40
and two human groups, the papilloma and the BK and JC virus
group.

Simian virus 40 (SV40) was isolated from rhesus

monkey cells and was shovm to induce tumors when injected
into hamsters (2,22,97).

In vitro SV40 is capable of malig-

nantly transforming human, mouse, rat, and hamster cells
(48,50).

The human papilloma virus has been shown to in-

duce benign tumors (112).

The human papovaviruses BK and

JC were isolated from immunologically compromised hosts.
BK virus (BKV) was isolated from the urine of a renal allograft recipient (25)Whereas JC virus (JCV) was first detected in brain cells of patients suffering from progressive
multifocal leukoencephalopathy (PML) (6?).

BKV has been

shown to be oncogenic in newborn hamsters (18,61,80,100)
although the ability to induce tumors varies between isolates.
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For example, the original BKV isolate has a low incidence
of tumor induction varying between 1% and 4% (80) whereas
another isolate, designated RF, has a high incidence of
tumor induction of

app~oximately

50% (18).

However, there

is no difference between the genomes of the original BK

In

and RF isolates (5?).

vitro BKV can malignantly trans-

form hamster, rabbit, mouse, and monkey cells (10,54,56,
69,70).

The JC isolate is highly oncogenic in newborn ham-

sters(6?).
The SV40, polyoma, BK, and JC viruses possess similar
physical properties.

They are composed of circular duplex

supercoiled DNA with molecular weights in the range of J.2J.4 x 106 daltons (2J).

The DNA is enclosed in a 45 nm

icosahedral protein capsid.

Due to the small size of the

genome, these viruses can code for only five or six proteins
and rely heavily on host cell functions for replication and
tr~scription

during their lytic cycle.

Cells in which viral infection culminates in virus
production such as cells of the natural host, are termed
permissive.

Papovaviruses can also infect cells of other

species termed non-permissive cells, which do not support
the replication of the virus.

Instead, infection of these

cells results occasionally in their transformation to a
malignant phenotype by a process that requires the expression of at least one viral gene.

3
The productive infection by a papovavirus begins with
adsorption and penetration of the cell by the virus.
is followed by uncoating of the nucleic acid.

This

The ensuing

lytic cycle has been divided into two phases, early and late.
The early phase lasts until the beginning of DNA replication.
During this phase, 19S virus specific early mRNA is synthesized.

This 19S mRNA encodes the tumor or T antigens.

The T antigens are nonstructural virus proteins found in
the nucleus of lytically infected and transformed cells
(7,24,31,34,35,36,72,100).

At this time, there appear to

be two T antigens; large T antigen (molecular weight
90,000) and small t antigen (molecular weight 17,000)
(15,73).

It has been shown that large T antigen binds to

viral DNA specifically at the origin of DNA replication,
indicating a possible role in viral DNA replication (3,13,
43,74,87,102).

Studies employing conditional lethal mu-

tants of SV40 have indicated that the large T antigen may
also be necessary for the initiation and maintenance of cell
transformation (11,47,55,66,102).

Similar studies of

SV40 deletion mutants have demonstrated that small t antigen may also be necessary for cell transformation (8,86).
Structurally, the T antigens of SV40 and BKV share several
tryptic peptides and are therefore related (19,58,75,76,
84,85).
A map of the SV40 genome is presented in Figure 1.
The map is divided into 100 minutes with reference to the
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Origin of DNA replication
(residues 5118-5197)
Leader linked to 19S mRNA
(residues 243-289) & to
VP1 16S mRNA(residues
243-445)

Codons for t(residues

5081-4559) and T antigens
(residues 5081-4837)

absent
in large T mRNA
(residues 44914836)
Sequence~

\

Sequences.absent
in small t mRNA
(residue~ 44914556)

VP2 codons(residues
480-1535)
Late
mRNA

Termination
in all 3 phases
(residues 45594592)
Main body of codons
for T antig~n
(residues 4490-2612)

VP codons(residues
3
~
834-1535)
Termination of
____VP & VPJ
2
(residue
1536)

~

VP 1 codons(residues

1423-2508)

Termination of VP1
(residue 2509)

Termination of T antigen
(residue 2611)

\
Fifmre 1

Schematic Representation of the SV40 Genome
(adapted from Reddy et al. (73)~
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EcoRI restriction endonuclease cleavage site.

The origin

of DNA replication and mRNA transcription is located at 0.67
on the map.

Early mRNA is transcribed in a counterclock-

wise direction from the E strand of DNA.

Late mRNA is

transcribed in a clockwise direction from the opposite
or L strand of DNA.

Transcription for both phases terminates

at 0.17 on the map.
Recently, several paradoxical observations have been
made concerning the two early gene products.

The basis

of this paradox is that nearly the entire early region
(2500-2600 nucleotides) would be required to encode a protein with a molecular weight of 90,000 (5).

Yet large dele-

tions within the early region mapping between 0.54 and 0.59
map units do not result in the production of an altered
large T antigen (79,81).

These deletion mutants fail either

to induce a detectable small t antigen or induce an altered
protein that has a decrease in molecular weight rcughly
corresponding to the size of the deletion (15).

There-

fore, the sequences mapping between 0.54 and 0.59 code
exclusively for portions of small t antigen.

In addition,

sequencing studies of SV40 DNA have shown that a transcript
of the early region would contain at least two termination
codons in each of the three reading frames near map position
0.54 (104).

Both early proteins can be translated in vitro

from mRNA sedimenting at 19S.

The small t antigen mRNA

sed~

6
ments slightly faster than the large T antigen mRNA 1(5).
These two mRNA molecules must therefore contain extensively
overlapping sequences.

Each of them is approximately the

size of the early region (5).

Small t antigen shares a

considerable fraction of its amino acid sequence with the
large T antigen (71).

This suggests that portions of the

two proteins are encoded in the same DNA sequences.
A resolution to this paradox has been developed.
Sequences comprising covalently continuous viral mRNA
molecules may arise from well separated regions on a viral
genome (1,4,14,46).
cess (5).

These molecules arise by a splicing

pr~

Subsequently, Berk and Sharp (5) demonstrated

that the two early SV40 mRNA species were spliced in such
a way that would account for the shared amino acid sequences
of large and small T antigens; the occurrance of termination
codons at 0.5l} map units; the phenotypes of vari?us deletion
mutants; and the relative size of both the T antigens and
the mRNA transcripts encoding them (5).

Subsequent sequence

studies have verified their hypothesis (106).

Similar

studies have been carried out with BKV, and the data appears
to be similar (Dhar, personal communication).
The late phase of the infective cycle is marked by the
onset of viral DNA replication and the synthesis of 16S
and 19S virus specific mRNA encoding the virus structural
proteins.

The major structural proteins, VPl, of SV40 and

--

BKV are somewhat related (3,18,53,59,113).

Tryptic peptide
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analysis indicates several similar peptides (3,53,59,113).
This similarity accounts for the serological neutralizing
crossreactivity of SV40 and BKV.

The lytic cycle terminates

in the assembly, maturation, and release of progeny virus.
The DNA of SV40 and BKV has been compared by restirction
endonuclease cleavage analysis, hybridization, and DNA sequencing.

The DNAs from SV40 and BKV have distinct restric-

tion endonuclease cleavage patterns (38).

From reassociatim

kinetics. it was concluded that there was an 11-12% sequence
homology between BKV and SV40 DNA (38,39,40,45,65).

This

homology was localized in the late region in the portion of
the genome coding for VPl.

No homology was detected between

the early regions of sv4o and BKV DNA (38,39,40,45,65).
These results were consistent with the minor crossreactivity between sv4o and BKV structural antigens.

It did not

explain the strong crossreactivity of the early non-structural T antigens.

Newell, et al., (62), utilized a more

sensitive, but less stringent test for examining DNA
homologies.

The two DNA molecules were jointed at a

tion endonuclease cleavage site common to both DNAs.
DNA was allowed to hybridize or "snap back".

restri~

The

Using this

technique, extensive homology in the early region was detected (62).

It had been postulated that the non-homology

between the early regions of SV40 and BKV DNA was due to
the degeneracy of the genetic code(45).

The degenerate

sequences might still code for a serologically crossreactive

8

protein.

Recent DNA sequencing work seems to support this

hypothesis (16,106,114, Dhar, personal communication).
The entire SV40 genome has been sequenced (l?,?J,9J,94,95,
96,10J,l06,115).

Preliminary work on the DNA sequence of

3KV

indicates extensive homology in the early region (16,106,
114, Dhar, personal communication).

Yet the sequences differ

enough so that hybridization under stringent conditions
might not detect nucleotide homology in this region (16,
106, 114).
One of the primary interests in papovavirus research
is the relationship of the virus to its tumor or transformed
cells.

Gerber and Kirschstein (JO) investigated the rela-

tionship of SV40 to the formation of ependymomas in hamsters
It was observed that cell-free
infectious virus.

tlli~or

extracts failed to yield

Hov:ever, infectious virus could be con-

sistently demonstrated when tumor cells were seeded onto
monolayers of permissive cells.

These observations were con-

firmed by other investigators (6,77).

Subsequently, evi-

dence was presented which suggested that the viral genome
was permanently present in an altered state in some of the
tumor cells (2?,28).

Virus release from tumor cells seeded

onto permissive cell monolayers could be enhanced by the
addition of UV-inactivated Sendai virus (29).

This result-

ed in cell fusion and the formation of virus producing heterokaryons.

Koprowski et al (49) postulated that the entire

SV40 genome was present in the tumor cells, but was unable

-

9

to be completely expressed.

Fusion with permissive cells,

resulting in the formation of heterokaryon cells, supplied
a function missing
co~plete

in the transformed cells which allowed

expression of viral genes and release of infectious

virus (49,108).

This phenomenon of virus production after

fusion with permissive cells was termed virus rescue.

The

failure of a tumor cell line to release infectious virus
was explained in several ways (21).

Only a fragment of the

SV40 genome was integrated into these nonyielder cells.
Alternatively, the complement of viral or cellular genes
might contain mutations which blocked the reversal of either
the integrated state, viral replication, or both.

Finally,

the incidence of fusion with susceptible cells might be too
low.

Subsequently; several investigators presented strong

evidence that the transformir:g viral genome persists in an
integrated state in the transformed cells (12,26,77,78,99,
109,111).

Analysis of DNA reassociation kinetics suggested

that there is one SV40 genome per host cell genome (26).
SV40 rescued from extensively passaged transformed cells
is indistinguishable from the wild type in that is has
the same markers associated with the original transforming
virus (101).

Later investigations of this phenomenon by

Huebner, et al (41), resulted in the isolation of defective
SV40 from transformed cells after cell fusion.

The rescued

virus had a buoyant density in CsCl expected of deletion
mutants.

These studies indicated that the entire genome

10

of SV40 might not be present in certain

svho

transformed

cells. If the entire genome was present, then it must exist
in a form which could not be properly excised.

Evidence

presented by Boyd and Butel (9) suggest that it is not the
resident

genome, but excision which is defective.

Presently, little is known about the regulation of
BKV gene expression in BKV transformed cells.

It is thought

that BKV large T antigen is necessary for viral DNA replication and cell transformation in analogy with its SV40 counterpart.

However, we have noted that the T antigen response of

BKV transformed baby hamster kidney cells (BK-BHK) is weak
as measured by immunofluorescence assay, although the cells
maintain a transformed phenotype.

Antisera produced against

BK-BHK cells have a low reactivity against BKV T antigen.
Based on these observations, we undertook studies to
determine the relationship between T antigen expression and
the virus rescuability in BK-BHK cells.

During these studies,

the novel cell clone, BK-BHK-L-29, was isolated which is
demonstrably T antigen negative yet releases infectious BKV
following cell fusion.

The rescued virus has been

characte~

ized for its ability to transform cells and induce T antigen
expression .

.

Through restriction endonuclease mapping and DNA-DNA
hybridization, the rescued virus has been compared with wild
type BKV.
here.

The results of these experiments are presented

11

It now appears that the isolation of the BK-BHK-L-29
clone may provide a model system to study the functions of
BKV early gene products in its transformed cells.
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Materials and Methods
Reagents:

Phosphate buffered saline (PBS) pH 7.2

contains 350 mM NaCl, 2.6 miir KCl, 1.6 rru'V1 NazHF04, 0.4 mM
WgC1 2 , and 0.9 mM CaC1 2 • TD buffer pH 7.0 consists of 137
mM NaCl, 5 ml\1 KCl, 0. 7 mM NaH 2 POLJ-, and 25 rru"VI tris (hydroxyethyl)aminomethane (Tris). Versene buffer pH 7.1 consists
of 0.6 mM

ethylenedia~inetetraacetic

acid (EDTA), 13.7

mM NaCl, 3 mM KCl, 8 ml\1 Na 2HP04, and 1 mM KHzP04. TES
buffer pH 7.2 is 10 mM Tris, 10 mm NaCl, and 10 mM EDTA.
Alsevers buffer is 0.11 M D-glucose, 0.027 M sodium citrate,
and 0.071 M NaCl pH 6.8.
Dulbecco' s modified Eagle medium (Dr.lE), fetal calf
serum (FCS), and calf serum (CS) were purchased from Flow
Laboratories.

Fluorescein-labelled rabbit anti-hamster IgG

was purchased from Cappel Laboratories.
resin was obtained from vrnatman Co.
'

obtained from Pharmacia Chemicals.

DE-52 ion exchange

Sephadex G-100 was
Horseradish peroxidase

type VI was purchased from Sigma Chemical Company.

The

restriction endonucleases Eco RI, Hpa II, and Hind III were
purchased from New England Biolabs ·while endonuclease

s1

was obtained from Miles I.aboratories.
Cell Cultures:

Mouse 3T3 cells (Balb c/3T3), first

established by Todaro and Green (105), African green monkey
kidney cells (BSC-1), and rat fibroblast cells were contin-

lJ
uously propagated as established cell lines in Dtlli supplemented with 10% FCS.

Polyoma transformed rat cells (Py-2403),

human embryonic kidney cells (HEK), and a continuous line
of human cells, HEK-JTJ-L-9 were also propagated on DME
containing 10% FCS.
Baby hamster kidney cells (BHK-21), initially established by Stoker and Macpherson (92), hamster fibroblast
cells (HF), BKV transformed BHK-21 cells, and BKV transformed hamster fibroblast cells (RF-194) were propagated
on DNlli supplemented with 10% CS and 10% tryptose phosphate
broth (TPB).
Virus growth and purification:

For preparation of BKV

stocks, HEK cells were infected at a multiplicity of infection (moi) of 0.1 (79).

Virus was harvested 18 days later

when virtually all of the cells showed cytopathic effects.
Virus was purified as described by Wright and di Mayorca
(llJ).

The viral lysates were subjected to six cycles of

freezing and thawing in a dry ice-acetone bath, and were
!

treated with 0.2% sodium deoxycholate for 1 hr at J?C.,
Large debris were removed by centrifugation for 15 min at
10,000 g.

The supernatant was centrifuged at 20C for 4 hr

at 64,000 g in a Beckman SW-25.2 rotor over a cushion of
10 ml of saturated KBr solution in TD buffer.

Virus from

the supernatant fluid would sediment in the KBr, as a
steep gradient is established during centrifugation.

The

....
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virus formed a visible band in the KBr which was collected
and dialyzed against TD buffer.

The volume of the dialyzed

material was brought to 7.5 ml with TD buffer and added to
3.45 g CsCl.

The solution was centrifuged at 20 C for 18

hr at 74,000 gin a Beckman type 50 rotor.

The single virus

band was collected, dialyzed against TD buffer, and stored
at -70 C.

55

Wild type SV40 and SV40 dl 1635, which contains a

base pair deletion between 0.715 and 0.73 units on the SV40
map, were propagated on BSC-1 cells and purified as described
for BKV.

Polyoma virus was propaged on Balb c/3T3 cells and

purified similarly.
Sendai virus was grown in specific pathogen-free 10
day old embryonated chicken eggs obtained from SPAFAS Co.
(48,109).

Eggs were infected with 128 hemagglutinating units

(HAU) of virus and incubated for 72 hr at 37 C.

The allantoic

fluids were collected, pooled, and centrifuged at 1000 g
for 10 min.

The supernatant was collected and centrifuged

at 46,000 g for 30 min, and the pellet resuspended to 0.1
the original volume in TD buffer.
refrigerated

overn~ght

1000 g for 10 min.

The virus suspension was

at 4 C followed by centrifugation at

The supernatant was collected and assayed

for virus by hemagglutination of guinea pig erythrocytes.
Sendai virus was stored at -70 C.
Plague Assay:

Virus was serially diluted in

Dr~

,
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~!)/'

after which 0.4 ml of each dilution inoculated in triplicate
onto cell monolayers.
HEK cells.

BKV was titrated in this manner on

SV40 was plaqued on BSC-1 cells.

was plaqued on 3alb c/3T3 cells.
for 2 hr at 37 C.

Polyoma virus

The virus was adsorbed

A 9 ml over layer of 1% agar in DIIIE sup-

plemented with 1% FCS was applied and the cultures kept at
37

c.

At either 18 days post infection (PI) for BKV, or 10

days PI for SV40 or Polyoma, the monolayers were overlayered
a second time with 5 ml of 1% agar, 1% FCS, and 0.005%
neutral red dye in nnm.
plaques 24 hr later.

The cultures were examined for

The neutral red dye is taken up only

by viable cells; therefore, viral plaques are readily
detected.
For plaque neutralization assays, 100 pfu of sample
virus were incubated with serial dilutions of either
rabbit hyperimmune anti-viral serum or normal rabbit serum
for 1 hr at 37 C.

The virus samples were then plaqued on

appropriate cell monolayers.

For serological identifica-

tion of virus, the neutralization of viral infection was
calculated by plaque reduction after incubation of virus
with virus specific antisera.
Infectious Center Assay:

BKV-transformed and normal

cells were serially diluted in DME and 0.5 ml of each
dilution inoculated in triplicate onto HEK cell monolayers.
After 2 hr at 37 C, 9 ml of DNffi containing 1% agar and 1%
FCS was applied.

Cultures were kept at 37 C for 3 weeks.
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At this time, a second overlayer consisting of DME, 1%
agar
"
,
v
1%0 -t<'•"S
' and 0.005% neutral red dye was applied.
Cultures were examined for plaques resulting from infectious
centers 24 hr later.
Hema~glutination

Assay:

washed once with PBS pH ?.8.

Human type 0 erythrocytes were
Hemagglutination assays

were done in microtiter plates.
in Alsevers buffer pH 6.5.

Virus was serially diluted

The total volume of each sample

was 0.1 ml, to which 0.05 ml of a 4% v/v erythrocyte solution was added.

The samples were refrigerated overnight

at 4 C and examined the following day for hemagglutination.
Hemagglytination Tnhibition Assay:

For serological

identification of BKV, anti-BKV serum #K-44-4 was used to
inhibit hemagglutination of human type 0 erythrocytes (53).
Experimentally, 0.1 ml anti-BKV serum was incubated at
56 C for 1 hr.

This was followed by the addition of 0.2

ml 0.01 M KI04 and subsequent incubation for 30 min at
room temperature.

The serum was serially diluted in micro-

titer wells and challenged with 8 hemagglutinating units
(HAU) of unknown virus.

After 30 min at room temperature,

human type 0 erythrocytes were added and the samples refrigerated overnight at 4

c.

A decrease in hemagglutination

titer of 4-fold or greater was considered to serologically
identify an unknown virus as BKV.
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Transformation of Cells in SoTt Agar:

The procedure

for transformation of cells in soft agar is described by
MacPhearson and Montanier (52).

The cells were harvested

by treatment with 0.5% trypsin and suspended in TD buffer
pH 6.8, supplemented with 1% FCS at a concentration of 1
x 10 6 cells per 0.1 ml. A 0.05 ml portion of this cell
suspension containing 5 x 105 cells was pipetted into a
small test tube.
cell of virus.

To each test tube was added 100-200 PFU/
The volume was adjusted to 0.5 ml with TD

buffer pH 6.8, and the virus-cell suspension incubated at
37 C for 1 hr with continuous stirring.

After adsorption,

any cell clumps were broken up by pipetting in a Pasteur
pipette drawn out to capillary size.

From this suspension,

0.2 m1 was added to 4.8 ml of Eagle's diluent consisting
of 80% DME, 10% calf serum that had been filtered through
a 0.4 mm millipore filter, and 10% tryptose phosphate broth
(TPB).

This suspension was combined with 10 ml of semi-

solid agar containing 40% 2X DME, 10% filtered calf serum,
10% TPB, and 40% of a 1.275% solution of agar, bringing the
final agar concentration to 0.33%.

From this suspension,

1.5 ml containing 2 x 104 cells were pipetted onto the centers of petri dishes containing a 5 ml layer of 0.5% agar
supplemented with 10% CS and DfJIE.

Cultures were checked

periodically for colonies which appeared after approximately
3 to 4 weeks incubation at 37 C.

Colonies of cells were

picked from the agar with a Pasteur pipette and grown in
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m.m

supplemented with

109~

CS and 10;1, TP3.

Plating Eff'iciency o·f' Trans formed Calls:

The trans-

formed cells were harvested and suspended in TD buffer pH
6. 8 to a concentration of 5 x 104 cells/ml. A 0. 2 ml portion of this suspension was mixed with 4.8 ml of Eagle's
diluent.

This suspension was added to 10 ml of semi-solid

agar and 1.5 ml of the resulting mixture was pipetted onto
petri dishes containing 5 ml of solid agar.

The cultures

were incubated for 3 to 4 weeks after which the colonies
were counted and the plating efficiencies determined as
a percentage of the total number of cells plated.
Tumorigenicity of Transformed Cells:

Transformed

cells were harvested with versen.e buffer pH 7.0, resuspended
in PBS buffer pH 7.2, and 1 x 105 cells inoculated subcutaneously between the shoulders of 2 to 3 week old male
Syrian hamsters.

When tumors had formed, the animals were

bled by cardiac puncture, sacrificed, and the tumors explanted.

To explant tumor tissue for culture, the area

around the tumor was swabbed with 70% ethanol and the skin
around the tumor cut with sterile scissors.
removed and washed ·with DME.

The tumors were

Connective tissue, fat, and

blood vessels were removed by scraping with a scalpel.
The dissected tumor tissue was washed again with Dl\TE,and a
small piece of solid tumor tissue removed and minced finely
with a scalpel.

The tissue was broken up further by pipet-
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ting and the tissue suspension distributed to petri dishes
containing Dr.'IE, 10% CS, and 10% TPB.

'.\'hen the explanted

cells had grown to confluency, they were harvested with
versene buffer pH 7.0, and stored in liquid nitrogen.
The sera collected from tumor-bearing animals were tested
for activity against BKV T antigen by immunofluorescence
assay.

Those sera with anti-T antigen reactivity were

pooled and used in assaying for T antigen in BKV transformed
cells.
Rabbit Skin Biousies:
U;I

Rabbits were anesthesized with

injections of Inovar at a dosage of l ml for the first

3 kg of body weight and 0.1 ml for every 0.3 kg thereafter.

An area on the neck was shaved and swabbed with

betadine.

A small piece of skin was removed with a pair

of sterile scissors.
sors and immersed in

The skin explant was minced with scis-

0.5% trypsin for 20 min.

collected by centrifugation and grown on

D~lli

?he cells were
supplemented

with 10% FCS.
Immunofluorescence Assay:

The immunofluorescence assay

for T antigen is a modification of that described by Pope
and Rowe ( 68).

Cells to be examined vrere grown on cover-

slips for 48 hrs.

Coverslips were washed twice for 3 min

each with PBS pH 7.1 and fixed in acetone for 5 min at
-20 C.

The cells were immediately washed 3 times with PBS

for 3 min each.

Coverslips were incubated with a 1:5

20
dilution of hamster anti-BKV-T antigen antisera (see
procedure above) for 1 hr at 37

c.

Coverslips were washed

twice for 3 min each with PBS and incubated with a 1:5
dilution of fluorescein-labelled rabbit anti-hamster
IgG (Cappel) for 1 hr at 37 C.
as before, mounted in

The coverslips were washed

glycero~and

examined under a Leitz

ultraviolet microscope.
Serum Absorptions:

Cultured cells were harvested and

subjected to 6 cycles of freezing and thawing in a dry iceacetone bath.

The lysate was centrifuged at 1000 g for

5 min and the pellet used for absorption of antibody.

A

pellet containing 107 lysed cells was resuspended in 0.5
ml serum.

The serum was incubated for 2 hr at 37 C.

The

cells were removed by centrifugation and the absorption
repeated once with fresh cell lysate.
Hamster antiperoxidase:

Hamster antiperoxidase antibody

was prepared according to the method of Dougherty et gl.
(20).

A 5 mg/ml solution of horseradish peroxidase in PBS

buffer pH 7.2 was prepared and mixed with an equal volume
of Freund's complete adjuvant.

For inoculation, 0.2 ml

containing 1 mg horseradish peroxidase was injected intramuscularly into the hind leg of 2 to 3 week old female
Syrian hamsters.

After 14 days, the hamsters were injected

with 0.5 mg of horseradish peroxidase in Freund's incomplete adjuvant (0.2 ml per injection).

On day 28, the
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hamsters were injected intraperitoneally with 0.2 mg horseradish peroxidase in 0.2 ml PBS buffer pH 7.2.

Six days

later the hamsters were bled by cardiac puncture, and the
individual sera tested for peroxidase activity.
were pooled and stored at -20

The sera

c.

To estimate the equivalence point of the antiperoxidase antisera, various quantities of peroxidase were mixed
with 0.2 ml portions of hamster antiserum and were incubated
for 48 hr at 4 C.

The immune precipitates were collected

by centrifugation at 27,000 g for 20 min, and washed once
with cold isotonic saline.

The precipitate was dissolved

by addition of 1 drop of 0.1 N NaOH and diluted to 1 ml
with saline.

The protein concentration of the immune preci-

pitates was determined by the method of Lowry (51).

Super-

natant fluids were analyzed for excess antigen or antibody
by diffusion in agar.
Preparation of Peroxidase-antiperoxidase (PAP) Com~:

The procedure for the preparation of the PAP complex

follows that of Sternberger et al. (90).

An equivalent

amount of peroxidase, previously determined to be 0.625 mg/
ml was added to 1 ml of hamster antisera and incubated for
2 hr at 37 C.

The immune precipitate was collected by centri-

fugation at 27,000 g for 20 min, washed 3 times with isotonic saline, and was resuspended in 2 ml of isotonic
saline containing 6.25 mg of peroxidase.

The pH was ad-

22

justed to 2.3 by addition of 0.1 N HCl to dissolve the immune
precipitate and was immediately neutralized to pH 7.2 with
0.1 N NaOH and 1 ml of a solution of 0.08 N sodium acetate
and 0.15 N ammonium acetate.

An equal volume of cold sat-

urated (I'TI{4 ) 2 so4 was slowly admixed to the solution.

The

mixture was stirred for 25 min, and the precipitate collected by centrifugation at 37,000 g for 15 min.

The precipi-

m\ oJ.

tate was washed once with 0.5Vsaturated (~lli4)zS04, dissolved in isotonic saline, and dialyzed against 6 1 of cold
isotonic saline for 48 hr at 4 C.

The PAP complexes were

tested for activity by mixing 0.1 ml PAP solution with
0.1 ml of a solution containing 25 mg of 3,3'-diaminobenzidine hydrochloride, 50 ml TD buffer pH 6.8, and 0.15 ml
of a 3% solution of hydrogen peroxide.

Enzyme activity was

indicated by the development of a brovm color.
Isolation of Hamster IgG:

Hamster IgG was isolated

by-the method of Stanworth (88).

DEAE-cellulose (DE-52,

Whatman) was equilibrated with PBS pH 7.5.

The exchanger

was cooled to 4 C and excess buffer removed by applying a
vacuum.

The moist exchanger was stirred into hamster serum

which had been previously equilibrated against PBS pH
(7 g wet exchanger per ml serum).

7.5

The mixture was refrig-

erated at 4 C for 2 hr with occasional stirring.

An equal

volume of cold PBS pH 7.5 was added and the liquid phase
collected by filtering over a vacuum.

The filtrate was
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concentrated by ultrafiltration and analyzed for purity by
reaction with rabbit anti-hamster IgG and rabbit antihamster serum (Cappel).
Preparation of Rabbit Anti-hamster IgG:

Rabbits were

inoculated with 0.1 mg purified hamster IgG in complete
Freund's adjuvant at 4 different sites.

Ten days later,

0.07 mg hamster IgG was administered intravenously.
rabbits were bled 10 days later.

The

The anti-hamster IgG

activity of the serum was checked by agar diffusion.
Conju~ation

Hamster IgG:

of Horseradish Peroxidase (HRPO) and

The procedure for conjugation is that describ-

ed by Nakane and Kawaoi (60).

Five milligrams of HRPO

were dissolved in 1.0 ml of freshly prepared 0.3 M NaHC03
pH 8.1.

To this solution, 0.1 ml of a 1% solution of

fluorodinitrobenzene in 100% ethanol was added and the
mixture stirred gently for 1 hr at room temperature.

A

-1.0 ml aliquot of 0.06 M Nai04 was added and the solution
stirred for 30 min at room temperature.

One ml of 0.16

M ethylene glycol was added and the solution stirred for 1
hr at room temperature.

The solution was dialyzed against

3 one-liter changes of 0.05 M carbonate buffer pH
4 C.

9.5 at

After.dialysis, 3 mg of hamster IgG were added and gent-

ly mixed for 3 hr at room temperature.

Following incubation

with IgG, 3 mg NaBH4 were added and the solution refrigerated overnight at 4 C. The HRPO-IgG conjugate was dialyzed
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against PBS pH 7.1 at 4 C overnight.

rrhe HRPO-IgG conju-

gate was purified on an 82 em x 1.5 em Sephadex G-100
column equilibrated in PBS pH 7.1.

Fractions were collect-

ed and the optical densities of the fractions taken at 40J
nm and 280 nm.

The fractions from the first peak were

pooled and used in all subsequent assays.
Immunoueroxidase Staining for BKV Large T Antigen:
Cell cultures grmvn on glass coverslips were washed 3 times
for 3 min each with Hanks BSS buffered at pH 7.4 with
0.05 M Tris (Flow Laboratories).

The cells were fixed by

immersion in 95% ethanol for 5 min followed by acetone for
5 min.

The coverslips were washed with PBS and flooded with

hamster anti-BKV-T antiserum for 10 min at 20 C.

The cover-

slips were washed 3 times for 3 min each with PBS and flooded
with rabbit anti-hamster IgG for 10 min at 20 C.

The cover-

slips were washed as before and treated with peroxidase
conjugated hamster IgG (obtained from Dr. R.IVI. Dougherty)
for 10 min at 20 C.

After washing aa before, the cells

were refixed for 20 min in 2.4% glutaraldehyde in PBS pH
7.2.

The coverslips were washed twice with PBS and the

bound peroxidase was visualized by the method of Graham and
Karnovsky (32).

The stained coverslips were dehydrated in

100% ethanol and mounted in permount.
Sendai Virus Inactivation:

Sendai virus was inactivat-
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ed with0-propiolactone (BPL) as described by Steplewski
and Koprowski (89).

BPL (Sigma Chemical Co., St. Louis, Mo.)

was added at a final concentration of 0.0125% and mixed well.
The virus mixture was

re~rigerated

by incubation at 37 C for 30 min.

at 4 C for 24 hr followed
The titer of the inacti-

vated virus was determined by hemagglutination of guinea
pig erythrocytes.

Viability was tested by inoculation into

the allantoic cavity of embryonated chicken eggs.

Inactivat-

ed virus was stored at -70 C.
BPL was tested for toxicity on cultured cells. Serial
dilutions of BPL were inactivated at 37 C for 30 min, and
0.5 ml of each dilution inoculated onto BHK-21 cell monolayers.

After overnight incubation at 37 C, the cells were
-·r·~>

harvested:counted, and the plating efficiency calculated
as the number of colonies divided by the number of cells
plated, multiplied by 100.
Sendai-mediated Cell Fusion:

The procedure for Sendai-

mediated cell fusion has been described. previously by Harris
and 'Natkins (36).

For fusion, 1 x 106 virus-transformed
cells were mixed with 2 x 106 permissive cells. The cells

were fused by addition of 5000 hemagglutinating units of
BPL-inactivated Sendai virus.

The samples were refrigerat-

ed at 4 C for 10 min followed by incubation at 37 C for
20 min.

Each sample was plated out and maintained on DME

supplemented with 5% FCS.

After 7 days, the cultures were
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assayed for infectious virus.

The cell cultures were scraped

from the plates and subjected to 3 cycles of freezing and
thawing in a dry ice - acetone bath.

The lysates were

assayed for infectious rescued virus by plaquing.the susceptable cells.

PEG-DMSO Fusion of Cells:

The protocol for cell fu-

sion with PEG-DMSO has been described by Norwood et al (64).
The cells to be fused were harvested and plated in mixed
culture at a ratio of 2:1, permissive:transformed on 60
mm x 15 mm petri dishes, and allowed to grow for 2h hr.
For fusion, 16 g PEG (molecular weight 6,000) were autoclaved for 15 min at 15 lbs pressure.

This was mixed while

still hot with 20 ml DI.'JE containing 15 % m:ISO (v/v).
final concentration of PEG is 44%.

The

The media was removed

from the mixed cell cultures by aspiration and 2 ml of the

PEG-Df/ISO added to the cultures.

After 1 min, the PEG-

DrJISO was removed by aspiration and the cells washed 4 times
with DivlE supplemented with 15% DTJISO followed by 2 washes
with DME alone.

The resulting heterokaryon cultures ·were

maintained on DNIE supplemented vli th 2% FCS.

The fusion

efficiency for these experiments was approximately 42%
as determined from cultures stained with methylene blue.
The heterokaryon cultures
were harvested after 7 days and
(
lysed by 6

O:v,
cycles~freezing

acetone bath.

and thawing in a dry ice -

The lysate was examined for infectious BKV

..
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by plaque assay and by infection of HEK cells.

Infected

cells were observed for cytopathic effects and assayed for
infectious virus by hemagglutination of human type 0 erythrocytes 21 days post-infection.
Extraction of Cell DNA:

Cell DNA was extracted as

described by Boyd and Butel (9).

Cells were harvested and

resuspended to a density of 3 x 107 per ml in 0.05 M TrisHCl, 0.1 J.\1 EDTA, and 0.01 M NaCl pH 7.1 (TES buffer).
For cell lysis, a 20% solution of sodium dodecyl sulphate
(SDS) was added to a final concentration-of 0.5% and the
pension incubated at 37 C with periodic swirling.

su~

An

equal volume of phenol saturated with TES buffer was added
and the mixture shaken for 10-15 min.

The phases were sep-

arated by centrifugation at 15,000 g for 10 min.

The aque-

ous phase containing the DNA was removed and the procedure
repeated 4 times.

An equal volume of chloroform-isoamyl

alc-ohol (24:1 v/v) was added to the aqueous phase and shaken for 5-10 min.

The phases separated as before, and the

aqueous phase collected.

The solution was brought to

0.1 M NaCl by addition of a 4 M stock solution of NaCl.
Two volumes of cold absolute ethanol were layered on top
of the aqueous solution and the DNA precipitated by winding
onto a glass rod.

sse concentration
sse. RNAse A was

The DNA was redissolved in 0.1 x

sse.

was adjusted to 2X by addition of 20X
added to a final concentration of 50

The
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~g/ml

and the solution incubated at 37 C for 2 hr.

SDS was

added to a final concentration of 0.5% and self digested
pronase was added to a final concentration of

100/~g/ml.

The solution was incubated at 37 C for 2 hr, after which the
solution was extracted once with TES-saturated phenol and
once with chloroform-isoamyl alcohol as described above.
After the final chloroform-isoamyl alcohol extraction, the
DNA was precipitated onto a glass rod by addition of 2
volumes of cold absolute ethanol and redissolved in a
minimum volume of 0.1 x sse (0.15 M NaCl, 0.015 M sodium
citrate).

The DNA was dialyzed against 3 1 of 0.1 x SSC

overnight, and was stored at -20

c.

The DNA was quanti-

tated by absorbance at 258 nm.
Extrgc~ion

of Viral DNA:

Viral DNA was extracted from

either infected cell extracts by the method of Hirt (37)
or from whole virions.
For Hirt extracted DNA, susceptible cells were infected at a multiplicity of 0.01 PFU/cell.

At the first sign of

viral cytopathic effect, the infected cells were washed
three times in TES buffer and lysed by addition of 0.6%
sodium dodecylsulphate in TES buffer.

After 30 min incu-

bation at 37 C, the lysates were poured into acid-cleaned
glass tubes and 5 M NaCl added to a final concentration of
1 M.

The tubes were gently mixed by inversion and refrig-

erated overnight at 4

c.

The lysates were centrifuged at
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15,000 rpm (Sorval SS-34 rotor) for 40 min.
was resuspended in TES buffer.

The pellet

The DNA solution was combined

with 1 gm of CsCl per milliliter of solution.
bromide v:as added to a

:~inal

Ethidium

concentration of 150 _;,..g/ml and

the samples centrifuged at 35,000 rpm (Beckman Type 40 rotor)
for

~-8

hr.

DNA bands vrere visualized under an ultraviolet

light and were collected from the gradient using a large
bore pipette to minimize shearing effects.
DNA was dialyzed against TD bu. ffer for

2L~

Purified viral
hr and quanti tat-

ed by absorbance at 258 nm.
DNA Infectivity:

A preparation of transformed cell DNA,

containing approximately 400)\.g/ml was mixed with an equal
volume of a 0.5 mg/ml solution of DEAE-dextran and 0.2 ml
of the DNA-DEAE-D suspension inoculated per culture of semiconfluent susceptible cells.

The inoculated cultures were

incubated for 30 min at 37 C after which the mono layers
were washed with Tris-buffered 1BME) pH 7 .1. The cultures
\ .., _ /
were over layered with 2X DME containing 1.0% agar and 2% FCS.
After 18 days, a second overlayer containing 2X DWE, 1.0%
agar, and 0.005% neutral red was applied.

The cultures were

examined for plaques 24 hr later.
Agarose Gel Electrophoresis:

Electrophoresis through

1.2% (wt/vol) agarose (Seakem) slab gels (20 em x 10 em x
0.5 em) was carried out in a buffer consisting of 89

w~
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Tris, 2.5 mM EDTA, and 8.9 mM boric acid pH 7.8.

Electro-

phoresis was for 9 hrs at 25 milliamperes which was
cient to clearly separate all DNA bands.

su::'fi~

The gels were

stained with a solution of 2 ,Ag of ethidium bromide per
milliliter o!: water and the stained DNA visualized under
an ultraviolet light.
Restriction Endonuclease Cleavage of Viral DNA:
I.

R. Eco RI - Reaction mixtures containing 100 ml\1 Tris

pH 7.5, 50 mM NaCl, 5 mM MgC1 2 , 100A.g bovine serum albumin (BSA), 5 units of R Eco RI, and

2~g

viral DNA were

incubated for 1 hr at 37 C.
II.

R Hpa II - Reaction mixtures containing 10

w~

Tris pH

2.5, 60 mM NaCl, 10 mlVI KCl, 100_Ag BSA, 20 units R Hpa II,
and 2 )'l..g viral DNA were incubated for 1 hr at 37 C.
III.

R Hind III - Reaction mixtures containing 7 wfl Tris

HCl pH 7. 9, 7 mm
R Hind III, and

37

r~1gCl2,
2~g

60 mM NaCl, 100 .,.A.g BSA, 5 units of

viral DNA were incubated for 1 hr at

c.
All restriction endonuclease digestions were stopped

by the addition of

10~1

of 5% SDS and the cleavage products

fractionated by electrophoresis in 1.2% agarose gels in
Tris-borate buffer ( 89 ml'ii Tris, 89 rlli·1 boric acid, 25 mTIT
EDTA, pH 8.2) at 2 v / em for 10 hr.

s1

nuclease mapping of viral DNA:

The procedure for S1

nuclease mapping has been described by Shenk et gl. (82).
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Heteroduplexes of Eco RI endonuclease-generated linear
BKV DNAs

vmre prepared by denaturing a mixture containing

l.J..,g each of the two DHAs in boiling water.

After 5 min,

NaCl was added to a final concentration of 0.2
DNA was reannealed at 68 C for 3 min.
was treated with s 1 nucelase (140 units

m and

the

The reannealed DNA
/~g

DNA) in the

presence of 4.5 mM Znso 4 , 280 mM NaCl, and 20~g/ml denatured
calf thymus DNA. After 30 min at 25 C, the reaction was
terminated by the addition of 0.05 volume of Tris base (2M)
and by increasing the Na+ concentration to 500 mM.

The DNA

was electrophoresed on a 1.2% agarose gel in Tris-borate
buffer (89 mm Tris, 89 mM boric acid, 25 mivT EDTA, pH 8.2)
at 20 v for 10 hr.
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Results

Cell

Tramj~QI.mations:

Growth in agar suspension is

considered the most stringent in yitrQ correlate for in
vivo oncogenicity (83).

The assay is based on the observ-

ation that normal cell growth is anchorage dependent, whereas malignant or transformed cell growth is anchorage independent (52,83).

To utilize this observation experiment-

ally, cell cultures were infected with BKV at a multiplicity of 125 PFU/cell, and plated in O.JJ% agar at a density of 2. 0 x lOLJ- cells/plate.

After J weeks, only BKV

infected BHK-21 cells yielded transformants at a frequency
of 0.4%, as shown in Table 1.

Polyoma infected f2408 cells

served as a positive control and grew at a frequency of
1.6%.

Ten colonies of each cell type, which were approx-

imately 1 mm in diameter, were cloned from the agar and
characterized further.

The plating efficiencies in agar

suspension of each BK-BHK clone are shown in Table 2.
Four of the BKV transformed BHK-21 cell lines (BK-BHK)
maintained very high plating efficiencies.

The Py2408

cell lines, shown in Table J, were somewhat lower than
the BK-BHK cell lines.
The four BK-BHK cell lines with the highest plating
efficiencies in agar suspension were examined for their
ability to initiate tumors in hamsters.

As shown in Table

4, all of the BK-BHK cell lines tested initiated tumors
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Table 1

. l
Cell Transformation in Agar Suspens1on

Infecting
Virus

Cell
Tyne

Transformation
Efficiency <%) 2

BKV

BHK-21

BKV

HEFJ

<o. 001

BKV

HEK

<0.001

BKV

<o. 001

BKV

HEK-3TJ-L9
4
73-ED-1

BKV

H~

<0. 001

BKV

RSF 6

<o. 001

Polyoma

f2408

1.6

None

f'2408

<0.001

None

BHK-21

0.4

<0.001

0.006

1.

Average-of four experiments

2.

Calculated as the number of colonies/number of infected
cells plated X 100.

3;

Hamster embryo fibroblast cells

4.

Marmoset fibroblast cell explant

5. Marmoset fibroblast cells
6.

Rabbit skin fibroblast cells

Table 2

Agar Plating Efficiencies of BKY Transformed
Cell
Line

Plating
Efficiency (%) 2

RF-194.3

14.5

BK-BHK-L-29

.38.0

BK-BHK-L-28

.31.1

BK-BHK-L-2.3

J0.5

BK-BHK-L-19

27 •.3

BK-BHK-L-18

9.6

BK-BHK-L-16

5.6

BK-BHK-L-14

12.6

BHK-214

Ce)Js

0.1

I.

Average of five experiments

2.

Calculated as the number of colonies/number of cells
plated X 100.

J.

Positive control

4.

Negative control

1

3.5

Table 3

Agar Plating Efficiencies of Polyoma
Transformed Cellsl
Cell
Plating
Line
Efficiency (~) 2

Py-2408-Cl-4

3.9

Py-2408-Cl-5

.5.8

Py-2408-Cl-6

6.4

Py-24-08-Cl-7

7.6

Py-2408-Cl-8

5.7

Py-2408-Cl-10

2.8

PySPlAJ
f24o8 4

20.2
<0.001

1.

Average of two experiments.

2.

Calculated as the number of colonies/
number of cells plated X 100.

J.

Polyoma transformed hamster cell line
used as a positive control.

4.

Negative control.
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Tumorigenicity of BK-BHK cells in Hamster~ 1
Number of
Number of Anim21s
Cell Line
Animals
with Tumors

Table 4

RF-194

3

o3

BK-BHK-L-29

3

3

BK-BHK-L-28

3

3

BK-BHK-L-23

3

3

BK-BHK-L-19

3

3

BHK-21

3

0

HEF

3

0

1.

Average of two experiments

2.

Represents the number of animals with palpable
tumors 21 days post inoculation.

3 • . Average appearance of palpable tumors was 54 days
post inoculation.
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in hamsters.

This experiment verifies the in vitro cor-

relate for malignancy; that is, the agar suspension assay.
The agar suspension assay is a very stringent assay
for cell transformation.

In some cases, cells which will

initiate tumors in animals will not grow in agar suspension.

Therefore, for those cell lines yielding negative

results in the initial agar transformation experiments,
we attempted a variation of the agar suspension assay in
an effort to increase the sensitivity for transformation.
Cultured cells were infected with BKV at a multiplicity of
1 PFU/cell.

The cells were grown in liquid medium for 5

to 10 passages and were plated in agar suspension.

No

observable colonies had appeared after 3 weeks in culture.
Large T Antigen Expression in BKV-transformed Cells:
Expression of nuclear T antigen was detected by an immunofluorescence assay.

The RF-194 cell line, which shows strong

T antigen expression was used as a positive control in all
experiments.

Negative controls included BHK-21 cells

and hamster embryo fibroblast cells from which RF-194 was
derived.

Tumor cell explants were also examined for T

antigen response.

In each case, the T antigen response of

each tumor explant was identical to that of the parent
inducing cell line.

Th3 data are summarized in Table

5.

As illustrated in Figure 2a, the RF-194 control cells were
strongly T antigen positive.

Several of the BK-BHK cell
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Xable 5

Immunofluorescent Detection of BKV T Antigen

Cell ]Jine

Ailti-BKV T
Antiserum

Uninoculated
Hamster Serum

-2

RF-194
BK-BHK-L-29
BK-BHK-L-28

+

BK-BHK-L-23

+

BK-BHK-L-19
BK-BHK-L-18
BK-BHK-L-16
BK-BHK-L-14

+

BHK-21

HEF
HEK
1.

Indicates several positive nu.clei in each microscopic field.

2.

Indicates the absence of positively staining . ·
nuclei from all microscopic fields.
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Fi~re

2

Immunofluorescent detection of BKV T antigen

in BKV transformed cells with anti-BKV T antigen serum.
A) RF-194 positive control; B) BHK-21 negative control;
C) BK-BHK-L-29; D) BK-BHK-L-28; E) BK-BHK-L-19.
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lines were also T antigen positive (Figure 2d-2e).
However,
2c).

BK-3HK-I~-29

was ':2 antigen negative (Figure

As noted previously, the BK-BHK-L-29 cell line main-

tained a high plating efficiency in agar suspension and induced tumors in hamsters.

Because there is a low frequency

of spontaneous transformation in BKV transformation experiments, we decided to examine this unusual line further
for evidence of BKV transformation and viral gene expression.
Immunoperoxidase Assay for Detection of Large T
Antigen:

We attempted to develop an immunoperoxidase assay

for BKV T antigens as a more sensitive means of detecting
viral proteins.

Initially, the technique described by

Sternberger (90) was used.

Hamster antiperoxidase serum

was prepared and quantitated as shown in Table 6.

The

hamster peroxidase-antiperoxidase (PAP) complex was prepared
as described earlier and was assayed for activity as shown
in Table 7.
PAP complex.

No peroxidase activity was detected in the
Using reagents obtained from Dr. R. M. Dough-

erty, we found that both the hamster PAP and rabbit antihamster serum were unsuitable for use in these experiments.
These results are shown in Table 8.

The assay was modified

by using peroxidase coupled hamster IgG (FOG) in place of
hamster PAP.

These

i~~unological

as described earlier.

reagents were prepared

Hamster FOG was eluted from a Seph-
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T~ble

6

Peroxidase
Added(mg)

1.

Equivalence Point of Hamster Antiperoxidase
Antiserum
.
Total Protein
Precipitated
(mg)

Antibody
Precipitated
(mg)

Supernatant
Test

0.05
0.075

0.6.3

0.58

excess ab

0.945

0.87

excess ab

0.1

1.265

1.16

excess ab

0.125

1.575

1.45

no excess
ab or ag

0.15

1.51

1 • .36

no excess
ab or ag

0.175

1.46

1.285

slight
excess ag

0.2

1.41

1.21

slight
excess ag

1.0

0.22

Average of two experiments.

excess ag
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Table ?

Activity of Peroxidase-Antiperoxidase Complexes
Sample

ActivitY

0.1 ml saline/0.1 ml peroxidase solution 1
0.1 ml saline/0.1 ml peroxidase substrate
0.1 ml peroxidase solution/0.1 ml peroxidase
substrate

+

0.1 ml PAP/0.1 ml peroxidase substrate
0.1 ml peroxidase conjugated rabbit antihamster globulin (Cappel)/0.1 m1
peroxidase substrate

+

0.1 ml FOG/ 0.1 ml peroxidase substrate
0.1 ml POG (Dougherty)/0.1 m1 peroxidase
substrate
1.

1.0 ug peroxidase/m1 saline

+
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Table 8

Reactivitv of Imrnunoperoxidase Reagents 1

Cell Line

Anti-Viral

Bridge

fAfLfo~2

S~r11m

An:ti~ery,m

RF-194

268-APJ

a-Ha-287-1 4

POG-35

4...

RF-194

268-AP

a-Ha-287-1

+/-

RF-194

268-AP

RF-194

a-RF-37

a-Ha-287-1
a-Ha-l 8

PAP-16
PAP-2 6
PAP-1

+I+I-

RF-194

a-RF-3

a-Ha-287-1

POG-J

J+

RF-194

268-AP

BK-BHK-L-19

268-AP

a-Ha-287-1

POG-3

21'

BK-BHK-L-28

268-AP

a-Ha-287-1

POG-3

2+

BK-BHK-L-29

268-AP

a-Ha-287-1

POG-J

BHK-21

268-AP

a-Ha-287-1

POG-J

1.
2.

a-Ha-l

Rea~:ti~m

POG-J

Outcome of two experiments was identical.
Peroxidase-antiperoxidase complex or peoxidase conju. gated hamster IgG.

3. Hamster anti-BKV T.serum (Dr. Dougherty)
4. Rabbit anti-hamster IgG (Dr. Dougherty)
5. Obtained from Dr. Dougherty
6.

Synthesized in this laboratory

?. Prepared in this laboratory (Hamster anti-BKV T serum)
8.

Rabbit anti-hamster IgG serum prepared in this laboratory.
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adex G-100 columr:, as shown in Figure

J.

Practions from

the first peak were pooled and concentrated by ultrafiltration.

The immunological reactivity of all reagents was

examined by diffusion in agar as shown in Figure 4.

From

these results, all reagents appeared to be suitable for the
assay.

However, no staining was observed when these rea-

gents were uced to detect T antigen.

Staining was only ob-

served using reagents obtained from Dr. R. M. Dougherty.
Although we were unsuccessful in developing an immunoperoxidase assay for BKV T antigen, we were able to confirm the
immunofluorescence data using the reagents obtained from
Dr. Dougherty. (Figure 5).
In addition, antisera against the BK-BHK cells was
examined for its ability to detect T antigen.

As shown in

Table 9, no T antigen reactivity was detected in RF-19L.1- cells
using antisera against BK-BHK-J.r29.

Weak T antigen reac-

tivity was detected with antisera against BK-BHK-L-28,
BK-BHK-L-19, and BK-BHK-L-23.

In all cases, the response

against T antigen in BK-BHK cells was weak or nonexistent.
Absorption of Anti-BKV

~

Serum with

Trans~ormed

Cells:

In order to further establish the lack of T antigen expression in the BK-BHK-L-29 clone, we absorbed anti-BKV
T antigen antisera with BK-BHK-L-29 cells, and tested the
absorbed serum for T antigen reactivity.
inconclusive.

The results were

Reactivity against large T antigen was non-
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Figure 4:

Immunoreactivity of reagents

us~d

in the POG

assay for viral T antigen. Center well: peroxidase-conjugated rabbit anti-hamster-IgG,

1) hamster POG, 2)

goat anti-peroxidase, J) hamster IgG,

{~mmonium

sulfate

precipitated), 4) rabbit anti-hamster IgG(Cappel Inc),

5) hamster IgG(Cappel Inc), 6) rabbit anti-hamster IgG
purified ·; iri this >; laboratory;

..

·

,··

..

Eigure

s~

Immunoperoxidase detection of BKV T antigen

in BKV transformed cells using hamster anti-BKV-T antigen
serum.

A) RF-194, B) BHK-21, C) BK-BHK-L-29, D) BK-BHK-L-28,

E) BK-BHK-L-19.

E
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Table 9

T antigen Detection Using Anti-BK-BHK Antisera_

Anti-Cell
Serum

Test Cell
Line

T-Antigen
Response

+

RF-194

RF-194

BK-BHK-L-29

RF-194

BK-BHK-L-28

RF-194

~I

BK-BHK-L-2.3

RF-194

+I-

BK-BHK-L-19

RF-194

+I-

Uninoculated
hamster serum

RF-194

49

sp8cifically "J.bsorbed out by BK-BHK-I,-29,
cells.

R~:.'-194,

ancl BEK-2l

This may have been due to either an initial low

antibody titer or because of the dilution of the serum during
the cell absorptions as has been previously reported by
o t her

.

.

exper1men~ers.

(r'"'
.J~J.

Virus Rescue Usin.z Sendai-mediated Cell Fusion:

The

BK-BHK and Py2408 cell lines were examined for their ability to release infectious virus after cell fusion using
BPL-inactivated Sendai virus.

Initially, we were interest-

ed in determining the toxicity of active and inactive BPL
on growing cells.

Confluent monolayers of BHK-21 cells

were treated with several concentrations of either
active or inactive BPL as described.

The cell cultures

were harvested after 24 hr, and the plating efficiency
of the BPL-treated BHK-21 cells determined.

As shown in

Table 10, there was no significant difference in the number
of cells harvested from each of the BPL-treated cell cultures.

The only notable effect of BPL was on the viability

of the cells.

Cells that were treated with BPL that had

been inactivated by heating to 37 C for 30 min at a concentration of 0.0125% plated with a high efficiency of 4?.2%.
No cell growth was observed for concentrations of BPL
greater than 0.0125%, regardless of inactivation.
In order to inactivate Sendai virus, and avoid the cell
toxicity effects of BPL, a killing profile was constructed.
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Table 10

BPL

(%)

Effects of 0-Propiolactone on BHK-21 Cells
Actiye
lnactive 1
Cells per
Plate(x 10 6 )

Cells per
flate(x 106 )

PE

0.1

1.9

0

1.2

0

0.05

5.26

0

5.25

0

0.025

1.0

0

1.17

0

0.0125

1.24

0

2.12

47.2

0.00625

).85

0

6.1

48.8

Untreated

4.8

58.)

5.4

51.1

1.

BPL was inactivated by heating at 37 C for JO min.

2.

Plating efficiency was calculated as the number of
colonies/number of cells plated x 100.
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Sendai virus was treated with several concentrations of
BPL.

The virus was inoculated into 9 to 10 day old embry-

onated chicken eggs, and the allantoic fluids assayed J
days later for hemagglutinating activity.

As shown in

Table 11, Sendai virus was inactivated at all concentrations of BPL tested.

As a result of these experiments,

Sendai virus was routinely inactivated at a BPL concentration of 0.0125%.
Cells were fused in the presence of 4000 HAU of BPL
inactivated Sendai virus as described.

As shown in Table

12, infectious virus was rescued only from Py2408 cells.
No infectious virus was released from any of the BK-BHK
cell lines using this technique.
Virus Rescue Using PEG-DMSO Mediated Cell Fusion:
Norwood et al. (64) have reported on increases in the efficiency of cell fusion using polyethylene glycol and dimethyl
sulfoxide mixtures.

Using this technique, infectious virus

was rescued from J of the BK-BHK clones as shown in Table
1).

It should be noted that infectious virus was rescued

only when BK-BHK cells were fused with HEK cells.

Virus

was not released after treatment of BK-BHK cells alone, indicating that PEG-Dr.'ISO was not inducing virus replication
alone.

Also, virus was not released from normal BHK-21

cells or HEK cells indicating that the source of the virus
was the BK-BHK cells.

The infectious virus was serologi-
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Table 11:

BPL Killing Profile on Sendai Virus

Concentration
BPLC%)

0.1

0

0.05

0

0.025

0

0.0125

0

0.00625

0

untreated
1.

Hemagglutinatin!
Units Recovered

1024

125 hemagglutinating units of Sendai virus
were treated with the BPL concentrations as
as described and inoculated into embryonated
hens eggs. This value represents the amount
of virus recovered after 3 days incubation
as described.

53

Table 12:
Cell
Line

Sendai Mediated Virus RescuQ___
Permissive
Host Cell

Virus Rescued 1
(PFU/ml)

RF-194

HEK

0

BK-BHK-L-29

HEK

b

BK-BHK-L-28

HEK

0

BK-BHK-L-23

HEK

0

BK-BHK-L-19

HEK

0

BK-BHK-L-18

HEK

0

BK-BHK-L-16

HEK

0

BK-BHK-L-14

HEK

0

Py2408-Cl-5

Balb c/3T3

6.0

X

Py2408-Cl-6

Balb c/JT3

3.2

X

10 1
103

Py2408-Cl-7

Balb c/3T3

2.2

X

102

BHK-21

HEK

0

f2408

Balb c/3T3

0

1.

PFU/ml of a h~terokary~n lysate
consisting of 1.0 x 10l fused cells.
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Table

1):

Ce1 l Line

Virus Rescue Following PEG-DMSO Fusion
Permissivi
Host Cell

Virus Rescued 2

RF-191~

HEK

0

RF-194

HEK-3T3-L-9

0

RF-194

none

0

BK-BHK-L-29

HEK

BK-BHK-L-29

HEK-3T3-L-9

0

BK-BHK-L-29

none

0

BK-BHK-L-28

HEK

BK-BHK-L-28

HEK-3T3-L-9

0

BK-BHK-L-28

none

0

BK-BHK-L-23

HEK

0

BK-BHK-L-23

HEK-3T3-L-9

0

BK-BHK-L-23

none

0

BK-BHK-L-19

HEK

BK-BHK-L-19

HEK-3T3-L-9

0

BK-BHK-L-19

none

0

BK-BHK-L-llJ-

HEK

0

BK-BHK-L-14

HEK-3T3-L-9

0

BK-BHK-L-14

none

0

BHK-21

HEK

0

BHK-21

HEK-3T3-L-9

0

BHK-21

none

0

1.
2.

1.0

2.0

1.4

X

X

X

103

10 2

102

Cells were either self-fused or fused with a permissive
host cell line.
Infectious titer of a heter~~aryon cell lysate
containing approximately 10 cells.
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cally identified as BKV by inhibition of hemagglutination
and neutralization of infectivity using BKV specific hyperimmune rabbit antisera.

(Tables 14 and 15).

The finding that the T antigen negative BK-BHK-L-29
clone releases infectious virus was unexpected, since
T antigen is thought to be necessary for papovavirus transformation.

It was important to determine if the lack of T

antigen expression in these cells was a stable characteristic, or only transient as has been reported in some cases
in other systems (44).

Subclones of several of the parent

BK-BHK clones were examined for their ability to express
T antigen and release infectious BKV after cell fUsion.
As shown in Table 16, each subclone maintained the characteristics of the parent clone.

Most importantly, subclones

of BK-BHK-L-29 were all T antigen negative virus yielders,
indicating that this is a stable characteristic.
In order to determine whether T antigen synthesis was
induced by heterokaryon formation, the BK-BHK-L-29 cells
were fused with HEK cells, and the heterokaryons examined
for T antigen expression 24 hr post-fusion.
not be detected.

T antigen could

Virus production in heterokaryons is

inefficient, about 10-6/heterokaryon (107).

Given this low

efficiency of virus rescue, it is possible that T antigen is
expressed in the minority of heterokaryons that produce virus.
Trgnsfection With Transformed Cell DNA:

Boyd and Butel
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~al21~
~am12J.~

14
6

Serological Identification of' Rescued Virus
Titer Without
Anti-BKV S~rum

Titer With
An:ti-BKV S~;rym 1

BKV-292 2

1:256

0

BKV-2813
BKV-1914

1:128

0

1:128

0

BKV-914765

1:512

0

1.

Virus samples were incubated with anti-BKV serum
before titration by hemagglutination assay.

2.

Virus ref!tcued from BK-BHK-L-29

J. Virus rescued from BK-BHK-L-28
4.

Virus rescued from BK-BHK-L-19

5.

Wild type BKV

6.

No inhibition of hemagglutination was observed
using uninoculated rabbit serum.
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Table 15

Neutralization of BKV 1Infectivity with AntiBKV Serum
Challen2e
Titer
102

Virus

Serum

BKV-292

3.5

X

BKV-292

anti-BKV
normal 4

3.5

X

BKV-PI-185

anti-BKV

5.1

BKV-PI-18

normal

5.1

Neutralization
Titer3
0
J.l

X

102
102

X

102

4.9

X

102

0
X

102

1.

Anti-BKV serum was challenged with a predetermined
amount of infectious BKV and the serum neutralizing
effects quantitated by plaque assay on HEK cells.

2.

Titer without anti-BKV serum.

J.

Titer after incubation with anti-BKV serum.

4.

Uninoculated rabbit

5.

Wild type BKV.

serum.

Table 16
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Virus Rescue and T Antigen Response in BK-BHK
Subclones

Cell Line

Titer of
Virus Rescued 2

6.7

BK-BHK-L-29
BK-BHK-L-29-a
BK-BHK-L-29-b
BK-BHK-L-29-c
BK-BHK-L-29-d
BK-BHK-L-29-e

X 103
3.9 X 10~
4.9 X 10 2
5.0 X 10
1.8 X 10 3
2.5 X 10 2

BK-BHK-L-28
BK-BH'n:-L-28-a
BK-BHK-L-28-b
BK-BHK-L-28-c
BK-BHK-J_,-28-d

2.0

2.0

X 10i
X

3.4

102

X 10
5.0 X 1011
5.0 X 10

BK-BHK-L-23
BK-BHK-L-23-a
BK-BHK-J_,-23-b
BK-BHK-L-23-c
BK-BHK-L-23-d
BK-BHK-L-19
BK-BHK-L-19-a
BK-BHK-L-19-b
BK-BHK-L-19-c

T Antige~
Response

+
+

+

+

+

0
0
0

0
0
2

1.4

X 10

1.0

X

7.5

X 10
2
X 10

4.6

BK-BHK-L-14
BK-BHK-L-14-a
BK-BHK-L-14-b
BK-BHK-L-14-d

0
0
0
0

BHK-21

0

103
2

+

+
+
+

+

+

+

+

1.

Average of three experiments

2.

Plaque titer in PFU/ml of a lysate of heterokaryons
containing approximately 10 7 cells.

3.

Determined by immunofluorescence assay
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(9) have been able to rescue infectious SV40 from previously
non-rescuable SV40 transformed cell lines, termed non-yielders, by trans:fection of permissive cells with transformed
cell DNA.

~e

examined BK-BHK cells for their ability to

release infectious BKV using the DEAE-dextran technique.
We included wild type BKV DNA as a positive control.

As

shown in Table 17, we were unable to rescue infectious
virus from any of the BK-BHK cell lines using this technique.
Using BKV DNA, infectious virus was produced at a titer of
3.89 x 103 PFU,?\.g viral DNA.

Because of this low infectiv-

ity of viral DNA, the chances of detecting infectious BKV
DNA in transformed cell DNA where it is about 104-fold less
concentrated, are very small.

Therefore, this method

appeared to be unsuitable for examination of virus rescuability.
Biological Characteristics of BKV-292:

The BK-BHK-Ir29

cell line is large T antigen negative, but also a virus
yielder.

This suggests the possibility that the virus

tran~

forming these cells may have been a variant of BKV, defective
for large T antigen synthesis.

If the transforming virus

was unable to induce large T antigen synthesis, then this
should be reflected in the ability of the rescued virus,
BKV-292, to induce large T antigen synthesis in transformed
cells.

Hamster cells were infected with either wild type

BKV or BKV-292 at a multiplicity of 100 PFU/cell.

The

tran~
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Table 17: Virus Rescue by Transfection
with Transformed Cell DNA
DNA
Source

RF-194

BK-BHK-L-29

BK-BHK-Ir28

BK-BHK-L-19

Permissive
Cell Host

Virus Yield
(PFU/ug DNA)

HEK

0

HEK-3T3-L-9

0

HEK

0

HEK-3T3-L-9

0

HEK

0

HEK-3T3-L-'9

0

HEK

0

HEK-JTJ-L-9
HEK

BHK-21

1.

HEK-3T3-L-9

0

HEK

0

HEK-JTJ-L-9

0

DNA extracted fDom wild type BKV-61677
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forming efficiency of wild type BKV and B}CV-292 v:ere cornparable (Table 18).

Several of the BKV-292 transformed

colonies were cloned from the agar and examined for large T
antigen expression and ability to rescue infectious virus.
As shown in Figure 6, BKV-292 does induce large T antigen
in BKV-292 transformed cells.
in Table 19.

The results are summarized

Five of the BKV-292 transformed cell lines

expressed BKV large T antigen.

Infectious BKV could be

rescued from only one of these cell lines.

In no case was

a large T antigen negative virus yielder observed.

It should

be noted that although the parental BK-BHK-L-29 clone rescued infectious BKV, virus rescuability in clones transformed
by BKV-292 was variable.

It appears, therefore, that virus

rescue is not a stable characteristic dependent upon the
transforming virus, but is rather a cell dependent property which may vary within a given cell population.
Examination o:f BKV-292 DNA:

Simultaneously with the

biological characterization o:f BKV-292, we examined the DNA
of the rescued virus :for genetic alterations.

Initially,

the viral DNA was screened :for large deletions or insertions
by calculating its molecular weight on a

0.?% agarose gel.

The DNA of BKV-292 comigrated with wild type BKV-DNA which
had a kno·..vn molecular weight o:f J. 25 x 10 6 dal tons.

Howley

.fU al. (J8) and Yang and Wu (Ill+), have demonstrated that

the DNA fragments produced by trea,tment with the restriction
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Table 18:
Infecting
Virus

Transforming Efficiency of BKV-292
Cell
Infected

Transformatio£
Efficiency(%)

BKV-292

BHK-21

0.49

BKV-PI-18

BHK-21

0.53

Uninfected

BHK-21

0.02

1.

Calculated as the number colonies/number cells
plated x 100.
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Figure 6:

Immunofluorescent detection of BKV T antigen

using hamster anti-BKV-T antigen serum.
B) BKR-2918, C) BKR-2919.

A) BKR-2912,

Table 19

Characterization of BKV-292 Transformed Cells 1

Cell Line
RF-194

T Antigen
Expression

Virus
Rescuability

+

BK-BHK-L-292

+

BKR-29103
BKR-2912

+

BKR-2913
BKR-2914
BKR-2916
BKR-2917
BKR-2918

+

BKR-2919
BHK-21
1.

Results of three experiments.

2.

Used as a positive control for virus rescue.

3.

BKR designates the cell. lines transformed by the
rescued virus BKV-292.
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endonucleases Hpa II and Ei:(J.ci III a:ce not lclentl.cal for dlfferent

BI~V

isolates.

The DNA of the original 3KV isolate

is cleaved 4 tines by Hind III while no cl·;:;avage occurs
using Hpa II.
isolntec~

In contrast, the BI:v-r.T:t strain, which 'Nas

from a patient

Vii

th ':lisiwtt-/;.ldrich syndrome ( 100),

contains only J Hind III cleavage sites, and in addition, is
cleaved by Hpa II once near the origin of viral DNA replication.

Based on these reports, vre compared wild type BKV

and BKV-292 DNA fragments generated by these two enzymes.
As shown in Figure 7, both isolates contain a Hpa II cleavage site.

Figure 8 illustrates that the fragments gener-

ated by Hind III are indistinguishable between these two
isolates.
Recognizing that the chance of finding a genetic
alteration by this method was small, we examined the DNA
of wild type BKV and BKV-292 by the
technique described by Shenk
single stranded DNA.

s1

nuclease mapping

fti gl.(82).

S1 attacks only

It will also attack DNA heteroduplexes

with a minimum of about a J base pair difference betvmen
two DNA molecules (110, Subramanian, personal communication)
The circular DNA's were converted to linear forms by treatment with the restriction endonuclease Eco RI, which produces a single breals::.

Equal amounts of the DNA samples

were mixed, heat denatured and annealed at 68 C for 3 min.
The annealed mixture of homoduplex DNA was scored for
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Figure 7

.

Comparison of wild type BKV and BKV-292 DNA

after digestion with the restriction endonuclease Hpaii.
DNA samples were digested as deseribed and 0.5-1.0 ug
digested DNA placed on a 1.2 % agarose gel.

The DNA

was electrophoresed as described in Materials and Methods
and was stained with ethidium bromide.

A) BKV-292 DNA

undigested; B) BKV-292 DNA digested with Hpaii; C) Form
I wild type BKV DNA . undigested; D) Form I wild type BKV
DNA digested with Hpaii.
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Figure 8:

Comparison . df wild type BKV, BKV-292, BKV res-

cued from BK-BHK-L-19

(B~I-191),

BK-BHK-L-28 (BKV-281) DNAs.

and BKV rescued from

DNA fragments were produced

after digestion with restriction endonuclease Hind III
and 0.5-1.0 ug digested DNA placed on a 1.2

% agarose

A) Wild type BKV DNA, B) BKV-191 DNA, C) BKV-281 DNA,
D) Bh.'"V-292 DNA.

gel.
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heterojuplexed regions oy S1
the DP:As vrere fractionated
agarose gel.

t~eatm9nt.

by

After treatment,

electrophoresis on a l. 2%

The results are shown in Figure 9.

s1

treatment of homoduplexes of each viral DNA yielded a single
linear band with the exception of BTC'l-PI-18 (?igure 7C).
Several minor bands ·were detected in this DNA which may be
due to imperfect reannealing under these conditions.
natively, some mutant BKV DNA may be present.

Alter-

However, this

was not detected in the previous restriction endonuclease
cleavage experiments (Figures

7 and 8).

Lane G of Figure

9 is a crude Hirt extracted wild type BKV DNA used as a

marker.

The lowest band represents form I DNA, while the

middle band is form II DI\:A.

s1

The uppermost band is cell DNA.

treatment of the positive controls consisting of annealed

wild type SV4-0 and SV40 dl 1635 gave the expected J bands
(Figure 9E).

The faster migrating bands represent the

two_products of S1 cleaved heteroduplex DNA.

The slowest

migrating band.consists of resistant homoduplex DNA.
No rapidly moving DNA species were generated by
treatment of annealed wild type and BKV-292 DNAs.
the

s1

s1

Rather,

treated DNAs migrate with the linear viral unit genome

controls.

Thus the rescued BKV-292 is indistinguishable from

wild type Bl\'"V.

It must differ by less than J base pairs.

.··

Figure

~

Comparison of wild type BKV and BKV-292 DNA

after hybridization and treatment with s 1 endonuclease.
The DNA of each virus was converted to li~ear form by
treatment with EcoRI.
with

The DNAs were hybridized, digested

s 1 , and electrophoresed on a 1.4% agarose gel.

The DNA was visualized by staining with ethidium bromide.

s 1 treated self-hybridized SV40 wild type DNA; B) s 1
treated self-hybridized SV40 dl 1635 DNA; C) s1 treated
self-hybridized wild type BKV DNA; D) s 1 treated selfhybridized BKV-292 DNA; E) s 1 treated wild type SV40/
SV40 d1 1635 DNA hybrids; F) s 1 treated wild type BKV/
A)

BKV-292 DNA hybrids; G) untreated, crude Hirt extracted
wild type BKV DNA.

A

B

c D

E

F

G
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Discussion

We have examined the relationship between the early
gene expression in BKV transformed BHK-21 cells, and the
functional state of the viral genome within these cells.
The BK-BHK cells were initially transformed in agar suspension and maintained high plating efficiencies in agar suspension throughout our studies.

All of the BK-BHK clones

tested initiated tumors in hamsters.

The efficiency of BKV

transformation is low occurring at a frequency of about
0.4% (Table 1).

We were unable to transform rabbit or

primate cells with BKV.

The efficiency of BKV infection

of these cell types may be low, although BKV transformation of rabbit and rhesus monkey cells has been reported
(10,56,70).

Dougherty (18) and Shah

u

.a,l. (80) have shown

that the oncogenicity of BKV isolates differ.

It may be

that the ability to transform cells in Y.i:tr.o. may also differ
between isolates.
Data accumulated to date have suggested that large T
antigen is necessary for the maintenance of transformation
(11,47,55,66,102).

These data have been based primarily

on experiments with conditional lethal mutants of SV40.
Cells transformed by these mutants are temperature sensitive for transformation.

The T antigen in these cells has

altered properties which has led to the conclusion that T
antigen is necessary for cell transformation.

BKV T antigen

?1
expression in BK-BHK cells is weak.

In several BK-BHK

clones, BKV T antigen could not be detected by immunofluorescence assay.

We attempted to develop an immunoperoxidase

assay for viral antigens as a more sensitive means for detection of viral gene products.

The immunoperoxidase assay

has been reported to be 10 to 100 times more sensitive than
immunofluorescence assays for viral antigens (20,90).
However, we were unsuccessful in developing such an assay
for BKV T antigens.

Each immunological component was tested

for reactivity against each of the other assay components
by double diffusion in agar (Figure 4).
components were immunologically reactive.

Individually, the
The hamster anti-

T antiserum was shown to be reactive in the immunofluorescence
assay forT antigen (Figure 2).

The rabbit anti-hamster

and POG complex appear to be reactive immunologically by
this method.

In addition, the FOG complex was reactive in

the assay for peroxidase activity described earlier.

How-

ever, when the reagents were used in a peroxidase assay for
T antigen on T-positive RF-194 cells, no reactivity was
detected.

At this time, we have no explanation for the

observed lack of reactivity.

However, we were successful

in performing the assay using reagents obtained from Dr.
R. M. Dougherty.

With these reagents, we were able to show

that the T antigen response of the BK-BHK clones was consistent, whether the method of detection was immunofluorescence
or immunoperoxidase assays (Tables 5 and 8).

In our hands,
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the sensitivity of the immunoperoxidase assay was no greater
than immunofluorescence assay for viral T antigen.

We

accordingly used the immunofluorescence assay for detecting
viral T antigen, as it provided a more reproducible assay.
In order to establish the functional state of the viral
genome in BK-BHK cells, we tried several methods for rescuing infectious virus.

There were several possible results

anticipated in attempting to rescue infectious BKV from the
BK-BHK cells.

The entire BKV genome might be present in the

transformed cells, and might exist in a rescuable state.
Alternatively, the BKV genome might be present in a non-rescuable state.

For example, if integrated; the DNA might not

be efficiently excised, or possibly only a fragment of the
genome might be present.

A last possibility is that the

tern used for examining virus rescuability might not be
tive enough to allow virus rescue.

Rescue by different

ods was necessary to rule out this possibility.

sy~

sens~
met~

All methods

for rescuing DNA viruses from these transformed cells involve
either cell fusion or DNA transfection.

We were unable to

rescue infectious BKV from any of the BK-BHK cells using
Sendai mediated cell fusion.

However, infectious polyoma

virus was rescued from Py2408 cells using this technique.
The inability to rescue infectious BKV using Sendai-mediated
cell fusion is probably due to the inefficiency of cell
fusion by this method.

It has been reported that the per-
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centage of cells fused using Sendai virus is less than 15%
(39).

Of the heterokaryons formed, only 0.5- 5% will release

virus (107).
transfections.

We were also unable to rescue BKV using DNA
Since our data shov.r a lov1 ar.1ount of infecti \.,._

ity of the BKV DNA per microgram used, we concluded that this
too is an inefficient means of rescuing BKV from BK-BHK cells.
BKV DNA is present at a low copy number of 3 to 5 copies
per cell genome in these cells, and therefore, would be

und~

tected (53).
Norwood et g].. (64) have reported a method for increasing the efficiency of cell fusion using polyethylene glycol
and dimethylsulfoxide.

Fusion efficiencies of greater than

50% have been achieved by this method (64).

This is the

most efficient method for cell fusion reported to date.
We felt the increased efficiency of cell fusion might increase the chances of detecting virus release.

Using this

technique, infectious BKV was rescued from three of the
BK-BHK clones(Table 13).

The rescued virus was identified

serologically as BKV (Tables 14 and 15).

The amount of

infectious BKV released from each of the BK-BHK clones was
much lower than that reported for SV40 rescue (108).
T antigen is thought to be necessary for viral DNA
replication and the maintenance of cell transformation.
Thus the isolation of the T antigen negative virus yielder
clone, BK-Bh'K-L-29 ·was a striking and unexpected result.
It was important to determine if these characteristics were
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stable or on::.y

as has been repo:ct2ci for certain

tra~1sient

SVI+O trans::'orm(~d

coll lines

(L~L~).

Each JK-3HK cell 1 ine

was subcloned and the subclones examined for their ability
to rescue BKV and express
ed the

fT1
J..

-J-•
anvlgen.

Each subclane

of the parent cell line.

maint~i~

Hetero1:a:::-y-

ons of BK-BillC-L-29 and HEK cells were examined and found to
be T antigen negative.

These results confirm that the BK-

BHK-L-29 clone is T antigen negative and yet a virus
yielder.
We investigated the possibility that the lack of T
antigen expression might be due to the loss of a viral
It is possible that the BK-BHK-L-29 cell line

function.

was transformed by a variant BKV species which i'las defective for T antigen expression.

If this were true, then the

defective nature of the transforming virus should be refleeted in the rescued virus, BKV-292.

This defect would

be in the form of a biochemically detectable alteration
in the viral genome, specifically in the region coding for
T antigen.

In addition, a genetic alteration would be

reflected in the biological properties of the virus.
If large T antigen is necessary for cell transformation,
then a BKV isolate defective for T antigen synthesis should
induce cell transformation at a significantly lower frequency.

As stated previously, BKV isolates are known to

differ in their restriction endonuclease maps (38,114).
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Based on these reports, the DNA of BKY-292 was compared to
wild type BKV DNA by examining the DNA fragments produced
by the restriction endonucleases Hpa II and Hind III.
The wild type BKV contains a R-Hpa II cleavage site which
is preserved in the rescued BKV-292 DNA (Figure ?).

No

difference was detected after digestion of BKY-292 and wild
type BKV DNA with R-Hind III (Figure 8).

Recognizing that

the chance of finding a genetic alteration by this method
was small, the DNA of BKV-292 was examined by the
nuclease mapping technique of Shenk

~a!·

(82).

s1
The DNA

of BKV-292 was hybridized to wild type BKV DNA after conversion to linear forms, and the hybrids treated with the single strand specific endonuclease S1•

Theoretically, this

technique should detect a single base mismatch.

However,

in practice, the lower limit is approximately a 3 base
mismatch (110, Subramanian, personal communication).
Given this limit to the technique, the DNA of BKV-292 was
homologous to wild type BKV DNA (Figure 9).
Since BKV-292 was genetically indistinguishable from
wild type BKV, we examined fUrther the biological characteristics of the rescued virus.

BKV-292 induced transformation

of BHK-21 cells with an efficiency comparable to wild type
BKV (Table 18).

Upon further examination of the BKV-292

transformants, we noted that infectious BKV could be rescued from one clone, BKR-2912.

More importantly, T antigen
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was detected in several of the BKV-292 transformed cells
(Table 19).

These results confirm the biochemical data on

the genetic makeup of BKV-292.

From this, we have concluded

that BKV-292 is essentially wild type.
There are several possible explanations for the observed
characteristics of the BK-BHK-L-29 clone.

It is possible that

the BK-BHK-L-29 clone is actually a spontaneously transformed BHK-21 cell line which passively carries BKV.

The

transformed characteristics are due to a cell genome alteration.

The BKV genome is not actively expressed; however,

it can be rescued by cell fUsion.
sibility.

This is an unlikely pos-

The frequency of BKV transformation·was 0.4%

while the frequency of spontaneous transformation was

o.oo6%. The frequency of formation of a spontaneously
transformed BHK-21 cell passively infected with BKV is the
product of these two frequencies or 0.0024%.

Because of'

this low frequency, this possibility appears unlikely.
A more complex explanation of the characteristics of
BK-BHK-L-29 involves the possibility of a two step mutantrevertant BKV.

Initially, transformation may have been C!aused

by a mutant of BKV.

This mutant might be unable to induce

T antigen but is fUlly capable of inducing transformation.
However, when virus rescue occurs, the mutant BKV may
revert to wild type.

Presently, we cannot assess this

hypothesis as we have no way of examining the genetic composition of the transforming virus without virus rescue.

??
The least complex explanation of the data is that the
inability to express T antigen may then reside with the host
cell.

Takemoto

~

al· (98) have previously reported isola-

tion of polyoma virus infected human fibroblast cells which
synthesize T antigen, but do not express a transformed
phenotype.
~

Similar results have been reported by Noonan

Ql. (6J) for SV40 infected rhesus monkey cells.

These

data indicate the T antigen, as detected by immunofluorescence assay, may not be sufficient for transformation.
It.is possible that a low level ofT antigen is synthesized
in these cells which is not detectable by histochemical
assays.

If this were true; however, one would not expect

rescue of BK virus with an efficiency comparable to the T
antigen positive clones.

Also, if low level T antigen

expression was undetected, it would be possible that some
of the subclones of the T antigen negative cells may eventually

s~ow

some T antigen positive cells.

This was never

observed.·
A more probable explanation would be that small t antigen, detected only by immunoprecipitation techniques, is
synthesized and functional (15).

Conceivably, BK virus

transformation may occur in the absence of detectable large
T antigen.

Recently, Hutchinson

~

al· (42) have reported

the presence of small t antigen in the absence of large
T antigen in polyoma transfomred BHK-21 cells.

Our assays

for T antigen were designed to detect the large T antigen.
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Small t antigen has only been described after. immunoprecipitation of viral proteins from transformed cells {15).

There-

fore, it might be possible that small t is expressed in the
BK-BHK-L-29 clone in the absence of large T antigen.

If

small t antigen is present in the absence of large T, then
this may elucidate the fUnctions of small and large T antigens for,BKV.
'

One possibility for a cell defect is the mRNA splicing
system.

Berk and Sharp {5) have shown the mRNA transcripts

encoding ' large and small T antigens are spliced differently.
Therefore, the host cell defect may lie in the cellular
ability to correctly splice the mRNA molecules in order
for proper expression of viral genes.

These possibilities

are currently under investigation and should provide evidence
for the function of the BK virus early gene products.
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APPENDIX A
Virus

Comments

BKV-PI-18

plaque purified wild type BKV

BKV-91476

plaque purified wild type BKV

BKY-292

BKV rescued from BK-BHK-L-29

BKV-281

BKV rescued from

BKV-191

BKV rescued from BK-BHK-L-19

SV40 strain 776

wild type SV40

SV40 dl 1635

SV40 deletion mutant with a 55 base
pair deletion at 0.715-0.73 on the
SV40 map

Polyoma

wild type polyoma virus

Sendai

obtained from Microbiological
Associates

BK-BW~-L-28
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APPENDIX B
Cell Line

.
o··l
S pec1es
0+. e o
r1~1n

Phenotype 2

HEK

human embryonic kidney

HEK-.3TJ-L9

human embryonic kidney

HF

marmoset monkey

p

73-ED-1

marmoset monkey

p

BSC-1

African green monkey kidney

c

RSF

rabbit skin fibroblasts

p

HEF

hamster embryo fibroblasts

p

BHK-21

baby hamster kidney5

c

f'2408

rat fibroblasts

p

Balb c/JTJ

mouse fibroblasts

p

Py2408

rat fibroblasts

T(polyoma) 6

PySPlA

hamster fibroblasts

T(polyoma)

RF-194

hamster fibroblasts

T(BKV)

BK-BHK

baby hamster kidney (BHK-21)

T(BKV)

BKR

baby hamster kidney (BHK-21)

T(BKV-292)

1. \\All cell lines were obtained from either Dr. E.O.
···\Major or Dr. G. di Mayorca.
2.

Denotes whether a particular cell is normal or
transformed.

J.

Denotes normal primary or secondary cell line

4.

Denotes contim>us cell line

5.

Stoker and MacPherson (92)

6.

Denotes transformed cell line

92

APPROVAL SHEET
The dissertation submitted by David Michael Olive has
been read and approved by the following committee:

Dr. Eugene 0. Major, Director
Assistant Professor, Microbiology, Loyola
Dr. Tadayo Hashimoto
Professor, Microbiology, Loyola
Dr. Marvin s. Stodolsky
Associate Professor, Microbiology, Loyola

Dr. Maurice L'Heureux
Professor, Biochemistry, Loyola
Dr. Allan Frankfater
Associate Professor, Biochemistry, Loyola
The final copies have been examined by the director of the
dissertation and the signature which appears below verifies
the fact that any necessary changes have been incorporated
and that the dissertation is now given final approval by
the Committee with reference to content and form.
The dissertation is therefore accepted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy.

!L-1/Date

76

